Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus - PubMed (original) (raw)
Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus
S Del Prato et al. J Clin Invest. 1993 Feb.
Abstract
Seven non-insulin-dependent diabetes mellitus (NIDDM) patients participated in three clamp studies performed with [3-3H]- and [U-14C]glucose and indirect calorimetry: study I, euglycemic (5.2 +/- 0.1 mM) insulin (269 +/- 39 pM) clamp; study II, hyperglycemic (14.9 +/- 1.2 mM) insulin (259 +/- 19 pM) clamp; study III, euglycemic (5.5 +/- 0.3 mM) hyperinsulinemic (1650 +/- 529 pM) clamp. Seven control subjects received a euglycemic (5.1 +/- 0.2 mM) insulin (258 +/- 24 pM) clamp. Glycolysis and glucose oxidation were quantitated from the rate of appearance of 3H2O and 14CO2; glycogen synthesis was calculated as the difference between body glucose disposal and glycolysis. In study I, glucose uptake was decreased by 54% in NIDDM vs. controls. Glycolysis, glycogen synthesis, and glucose oxidation were reduced in NIDDM patients (P < 0.05-0.001). Nonoxidative glycolysis and lipid oxidation were higher. In studies II and III, glucose uptake in NIDDM was equal to controls (40.7 +/- 2.1 and 40.7 +/- 1.7 mumol/min.kg fat-free mass, respectively). In study II, glycolysis, but not glucose oxidation, was normal (P < 0.01 vs. controls). Nonoxidative glycolysis remained higher (P < 0.05). Glycogen deposition increased (P < 0.05 vs. study I), and lipid oxidation remained higher (P < 0.01). In study III, hyperinsulinemia normalized glycogen formation, glycolysis, and lipid oxidation but did not normalize the elevated nonoxidative glycolysis or the decreased glucose oxidation. Lipid oxidation and glycolysis (r = -0.65; P < 0.01), and glucose oxidation (r = -0.75; P < 0.01) were inversely correlated. In conclusion, in NIDDM: (a) insulin resistance involves glycolysis, glycogen synthesis, and glucose oxidation; (b) hyperglycemia and hyperinsulinemia can normalize total body glucose uptake; (c) marked hyperinsulinemia normalizes glycogen synthesis and total flux through glycolysis, but does not restore a normal distribution between oxidation and nonoxidative glycolysis; (d) hyperglycemia cannot overcome the defects in glucose oxidation and nonoxidative glycolysis; (e) lipid oxidation is elevated and is suppressed only with hyperinsulinemia.
Similar articles
- Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A, Alford F, Henriksen FL, Christopher M, Beck-Nielsen H. Vaag A, et al. Diabetologia. 1995 Mar;38(3):326-36. doi: 10.1007/BF00400638. Diabetologia. 1995. PMID: 7758880 - Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.
Thorburn AW, Gumbiner B, Bulacan F, Wallace P, Henry RR. Thorburn AW, et al. J Clin Invest. 1990 Feb;85(2):522-9. doi: 10.1172/JCI114468. J Clin Invest. 1990. PMID: 2105341 Free PMC article. - Effects of physiological hyperinsulinemia on the intracellular metabolic partition of plasma glucose.
Bonadonna RC, del Prato S, Bonora E, Gulli G, Solini A, DeFronzo RA. Bonadonna RC, et al. Am J Physiol. 1993 Dec;265(6 Pt 1):E943-53. doi: 10.1152/ajpendo.1993.265.6.E943. Am J Physiol. 1993. PMID: 8279550 - Insulin action and substrate competition.
Groop LC, Ferrannini E. Groop LC, et al. Baillieres Clin Endocrinol Metab. 1993 Oct;7(4):1007-32. doi: 10.1016/s0950-351x(05)80243-5. Baillieres Clin Endocrinol Metab. 1993. PMID: 8304911 Review. - Insulin resistance in skeletal muscles in patients with NIDDM.
Beck-Nielsen H, Vaag A, Damsbo P, Handberg A, Nielsen OH, Henriksen JE, Thye-Rønn P. Beck-Nielsen H, et al. Diabetes Care. 1992 Mar;15(3):418-29. doi: 10.2337/diacare.15.3.418. Diabetes Care. 1992. PMID: 1559409 Review.
Cited by
- Future is Brighter: New Potential Paradigm-Shifting Medications and Regimens for Diabetes and Obesity.
Al-Horani RA, Aliter KF, Aliter HF. Al-Horani RA, et al. Curr Diabetes Rev. 2024;20(8):84-97. doi: 10.2174/0115733998276832231124170324. Curr Diabetes Rev. 2024. PMID: 38275036 Review. - A Novel Composite Indicator of Predicting Mortality Risk for Heart Failure Patients With Diabetes Admitted to Intensive Care Unit Based on Machine Learning.
Yang B, Zhu Y, Lu X, Shen C. Yang B, et al. Front Endocrinol (Lausanne). 2022 Jun 29;13:917838. doi: 10.3389/fendo.2022.917838. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846312 Free PMC article. - De Novo Glycine Synthesis Is Reduced in Adults With Morbid Obesity and Increases Following Bariatric Surgery.
Tan HC, Hsu JW, Tai ES, Chacko S, Wu V, Lee CF, Kovalik JP, Jahoor F. Tan HC, et al. Front Endocrinol (Lausanne). 2022 Jun 9;13:900343. doi: 10.3389/fendo.2022.900343. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35757406 Free PMC article. - Enhancement of anaerobic glycolysis - a role of PGC-1α4 in resistance exercise.
Koh JH, Pataky MW, Dasari S, Klaus KA, Vuckovic I, Ruegsegger GN, Kumar AP, Robinson MM, Nair KS. Koh JH, et al. Nat Commun. 2022 Apr 28;13(1):2324. doi: 10.1038/s41467-022-30056-6. Nat Commun. 2022. PMID: 35484130 Free PMC article. - Insulin action at a molecular level - 100 years of progress.
White MF, Kahn CR. White MF, et al. Mol Metab. 2021 Oct;52:101304. doi: 10.1016/j.molmet.2021.101304. Epub 2021 Jul 15. Mol Metab. 2021. PMID: 34274528 Free PMC article. Review.
References
- Diabetologia. 1987 Jun;30(6):437-40 - PubMed
- J Clin Invest. 1987 Sep;80(3):655-63 - PubMed
- J Clin Invest. 1990 Jun;85(6):1785-92 - PubMed
- Am J Physiol. 1990 Jun;258(6 Pt 1):E923-9 - PubMed
- J Clin Invest. 1988 Aug;82(2):486-94 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical